Added to YB: 2023-08-18
Pitch date: 2023-08-18
ALPN [bullish]
Alpine Immune Sciences, Inc.
+409.97%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alpine Immune Sciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of immunotherapies through protein engineering technologies for treating autoimmune and inflammatory diseases.
Market Cap
$4.5B
Pitch Price
$12.74
Price Target
N/A
Dividend
N/A
EV/EBITDA
-86.71
P/E
-95.45
EV/Sales
73.61
Sector
Biotechnology
Category
N/A
Show full summary:
ALPINE IMMUNE SCIENCES INC ALPN
A summary for this pitch has not been created yet.
Read full article (0 min)